EC Number | Application | Comment | Organism |
---|---|---|---|
1.3.1.44 | medicine | enzyme is a target for drugs in treatment of tuberculosis | Mycobacterium tuberculosis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.1.1.100 | selection of an Escherichia coli, BL21(DE3)NH host that stably expresses mutant forms of 3-ketoacyl-ACP(CoA) reductase | Mycobacterium tuberculosis |
1.3.1.44 | gene inhA, overexpression of stable mutant enzymes in Escherichia coli strain BL21(DE3) | Mycobacterium tuberculosis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.3.1.38 | K165A | normal expression in Escherichia coli | Mycobacterium tuberculosis |
1.3.1.38 | K165Q | normal expression in Escherichia coli | Mycobacterium tuberculosis |
1.3.1.38 | Y158F | expression in Escherichia coli sub-population BL21(DE3)NH | Mycobacterium tuberculosis |
1.3.1.44 | K165A | site-directed mutagenesis, mutation of putative catalytic residue | Mycobacterium tuberculosis |
1.3.1.44 | K165Q | site-directed mutagenesis, mutation of putative catalytic residue | Mycobacterium tuberculosis |
1.3.1.44 | additional information | construction of stable mutants for optimization of expression of enzyme in Escherichia coli, absolutely dependent on IPTG, phenotype alterations, overview | Mycobacterium tuberculosis |
1.3.1.44 | Y158F | site-directed mutagenesis, mutation of putative catalytic residue, mutant can only be stably expressed in Escherichia coli strain BL21(DE3) if altered to a soluble enzyme form dependent on IPTG induction | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.44 | isoniazid | drug to treat tuberculosis | Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.100 | Mycobacterium tuberculosis | - |
- |
- |
1.3.1.38 | Mycobacterium tuberculosis | - |
- |
- |
1.3.1.44 | Mycobacterium tuberculosis | - |
enzyme is a component of fatty acid synthase type II | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.3.1.38 | acyl-CoA + NADP+ | - |
Mycobacterium tuberculosis | trans-2,3-dehydroacyl-CoA + NADPH | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.100 | 3-ketoacyl-ACP(CoA) reductase | - |
Mycobacterium tuberculosis |
1.3.1.38 | 2-trans enoyl-ACP(CoA) reductase | - |
Mycobacterium tuberculosis |
1.3.1.38 | InhA | - |
Mycobacterium tuberculosis |
1.3.1.44 | ENR | - |
Mycobacterium tuberculosis |
1.3.1.44 | More | enzyme belongs to the short-chain dehydrogenase/reductase family, enzyme is a component of fatty acid synthase type II | Mycobacterium tuberculosis |
1.3.1.44 | trans-2-enoyl-ACP(CoA) reductase | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.38 | NADP+ | - |
Mycobacterium tuberculosis | |
1.3.1.44 | NADH | dependent on | Mycobacterium tuberculosis |